MEDREH · EP 13 · PALLIATIVE
Before You Listen
Episode Setup
- Topic in one line: the conceptual and operational distinction between palliative care (any-stage symptom management delivered alongside curative treatment) and hospice care (Medicare-defined comfort care for a prognosis of six months or less), the World Health Organization (WHO) three-step analgesic ladder with strong-opioid first-line for severe cancer pain, opioid rotation using equianalgesic conversion with a 25 to 50 percent dose reduction for incomplete cross-tolerance, methadone as a refractory-pain agent with N-methyl-D-aspartate (NMDA) antagonism and complex pharmacokinetics, low-dose opioids and trigeminal-mediated fan therapy as first-line treatment for refractory dyspnea, glycopyrrolate-versus-scopolamine selection for terminal secretions when delirium is a concern, the Setting-Perception-Invitation-Knowledge-Emotions-Strategy (SPIKES) protocol for serious-news communication, the actionable-orders distinction between Physician Orders for Life-Sustaining Treatment (POLST) and statement-of-preferences advance directives, the substituted-judgment-then-best-interest hierarchy for surrogate decision-making, and the Palliative Performance Scale (PPS) and Karnofsky Performance Status (KPS) prognostication thresholds. Part 2 (MEDREH-13-b) continues with rehabilitation goal-shifting in serious illness and the four-condition principle of double effect.
- Prerequisites: delirium framework from MEDREH-09 (Confusion Assessment Method, hyperactive versus hypoactive phenotypes, haloperidol pharmacology), opioid pharmacology and equianalgesic principles from REHAB-01, and the goal-setting and goal-shifting framework from MEDREH-07 (Geriatrics).
- Runtime: 1 hour 8 minutes (full episode); Part 1 covers approximately the first 55 minutes of audio.
Vignette. A 67-year-old woman with metastatic pancreatic adenocarcinoma is admitted to inpatient rehabilitation following a debulking laparotomy. She has known peritoneal carcinomatosis and is receiving palliative chemotherapy. Her oncologist estimates a prognosis of three to four months. On arrival she has a Palliative Performance Scale score of 50 percent, an Eastern Cooperative Oncology Group performance status of 3, and the following symptom burden: pain rated 8 out of 10 (mixed visceral and neuropathic), fatigue, anorexia with a 9 kg weight loss over six weeks, episodic nausea, opioid-induced constipation on her current regimen of long-acting morphine 60 mg twice daily plus immediate-release morphine 15 mg every 4 hours as needed, and breathlessness on minimal exertion despite an oxygen saturation of 96 percent on room air. She is alert and asks the team directly, “Am I dying?” Her son tells the rehabilitation physician privately that he does not want her told the truth.
Which conversational protocol should structure the conversation with this patient; what is the next analgesic step; what is the first-line treatment for her dyspnea given her oxygen saturation; and what is the appropriate response to the son’s request?
(Answer at the end of this chapter)
Section 1: Palliative Care Versus Hospice and the Medicare Hospice Benefit
Bottom line: palliative care is specialized symptom-and-stress-focused care appropriate at any stage of serious illness and delivered concurrently with curative treatment, while hospice is a specific Medicare-defined comfort-only model for patients with a prognosis of six months or less if the disease runs its normal course; the Temel trial in metastatic non-small cell lung cancer demonstrated that early integration of palliative care extended median survival by 2.7 months while improving quality of life and reducing depression, directly disproving the misconception that palliative care means giving up; the Medicare Hospice Benefit (Part A) covers two 90-day certification periods followed by unlimited 60-day periods as long as the patient meets the six-month prognosis criterion, and election is fully revocable at any time; all hospice is palliative care, but not all palliative care is hospice.
Palliative care is interdisciplinary medical care focused on relieving the symptoms, pain, and stress of serious illness. The defining and most heavily tested feature is that palliative care is appropriate at any stage of serious illness and is delivered concurrently with curative and life-prolonging treatment. A patient receiving curative-intent chemotherapy for stage III colon cancer can and should simultaneously receive palliative care for pain, nausea, fatigue, and psychosocial distress. The two approaches are not in competition. The palliative team manages the collateral damage of cure while the oncology team targets the disease.
The Temel trial (NEJM 2010) randomized patients with newly diagnosed metastatic non-small cell lung cancer to early integrated palliative care plus standard oncology versus standard oncology alone. The early-palliative-care group had better quality of life, less depression, less aggressive end-of-life care, and a 2.7-month longer median survival (11.6 versus 8.9 months). This finding is the canonical refutation of the lay misconception that palliative care means giving up. The likely mechanisms are better symptom control allowing tolerance of disease-directed therapy and reduced psychological distress, which together lower the physiologic burden of unmanaged pain, anxiety, and cachexia.
Hospice care is a regulatory model of care for patients with a prognosis of 6 months or less if the terminal illness runs its normal course. Two physicians, typically the hospice medical director and the patient’s attending physician, must attest to the prognosis at election. Under the Medicare Hospice Benefit (Part A), the patient elects to forgo curative treatment for the terminal diagnosis and receives comprehensive comfort-focused services: medications related to the terminal diagnosis, durable medical equipment, nursing visits, home health aide services, chaplaincy, social work, volunteer support, and bereavement services for the family for 13 months following the patient’s death. Hospice can be delivered at home, in a dedicated hospice facility, in a skilled nursing facility, or in a hospital. Election is fully revocable at any time, and the patient retains the right to return to curative-intent treatment.
::: {.callout-tip}
## Mnemonic — “Concurrent or Comfort-Only”
Palliative care runs concurrent with any disease-directed treatment at any stage. Hospice is comfort-only and requires a six-month prognosis. If a board stem says the patient is still receiving chemotherapy, the answer is palliative care, not hospice. :::
The group getting early palliative care alongside their cancer treatment didn’t just have a dramatically better quality of life and less depression. They actually lived longer. Their median survival was extended by 2.7 months compared to the standard care group.
— MEDREH-13 podcast, ~3:00